Psychemedics Corporation Launches New Ketamine Hair Testing Service
August 29, 2024 09:00 ET
|
Psychemedics Corporation
Psychemedics Corporation, a global leader in hair testing, announces the launch of its new ketamine hair testing solution.
Psychemedics Recognized as a Top 10 Employee Health Testing Services Provider
March 21, 2024 09:00 ET
|
Psychemedics Corporation
Psychemedics Corporation announces its recognition as one of the Top 10 Employee Health Testing Services Providers for 2024 by ManageHR
Global Drug of Abuse Testing Market Analysis Report 2023: Increasing Government & Non-Government Institutions Initiatives to Combat Drug-Related Mortalities
September 08, 2023 04:03 ET
|
Research and Markets
Dublin, Sept. 08, 2023 (GLOBE NEWSWIRE) -- The "Global Drug of Abuse Testing Market (By Product Type, Sample/Test Type, Drug Type, End Users/Setting Type, Region), Regulatory Status, Recent...
Drugs of Abuse Testing Technologies and Global Markets Report 2023 Featuring Abbott Laboratories, Beckmann Coulter, Roche Diagnostics, Quest Diagnostics, LifeSign and Thermo Fisher Scientific
February 27, 2023 11:03 ET
|
Research and Markets
Dublin, Feb. 27, 2023 (GLOBE NEWSWIRE) -- The "Drugs of Abuse Testing: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering. The current report offers a...
Global Drug of Abuse Testing Market Analysis Report 2022-2027: Product Type, Sample / Test Type, Drug Type, End Users, Impact of COVID-19, Regulatory Status, Recent Developments, Company Profiles
May 05, 2022 05:08 ET
|
Research and Markets
Dublin, May 05, 2022 (GLOBE NEWSWIRE) -- The "Global Drug of Abuse Testing Market (By Product Type, Sample / Test Type, Drug Type, End Users / Setting Type, Region), Impact of COVID-19, Regulatory...
Psychemedics Announces First Quarter Results
May 13, 2020 17:15 ET
|
Psychemedics Corporation
ACTON, Mass., May 13, 2020 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD) today announced first quarter financial results for the period ended March 31, 2020. The Company’s revenue for...